We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

29 hedge funds and large institutions have $2.94M invested in Microbot Medical in 2023 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

21% more funds holding

Funds holding: 24 → 29 (+5)

0% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 7

0.92% less ownership

Funds ownership: 18.87% → 17.95% (-0.92%)

30% less capital invested

Capital invested by funds: $4.2M → $2.94M (-$1.26M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $4K

Holders
29
Holders Change
+5
Holders Change %
+20.83%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
7
Closed
1
Calls
–
Puts
$4K
Net Calls
-$4K
Net Calls Change
-$4K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$68.8K
2
Millennium Management
Millennium Management
New York
+$44K
3
Northern Trust
Northern Trust
Illinois
+$8.93K
4
UBS Group
UBS Group
Switzerland
+$8.82K
5
Morgan Stanley
Morgan Stanley
New York
+$8.14K

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$266K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$77.7K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$26.9K
4
CAN
Cetera Advisor Networks
California
-$2.66K
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$444
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$1.25M -$266K -90,000 -13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$543K -$26.9K -9,096 -3%
BlackRock
3
BlackRock
New York
$317K +$1.4K +474 +0.3%
AA
4
AlphaCentric Advisors
Puerto Rico
$208K – – –
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$138K -$77.7K -26,248 -28%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$110K – – –
Morgan Stanley
7
Morgan Stanley
New York
$81.3K +$8.14K +2,751 +8%
State Street
8
State Street
Massachusetts
$54.2K – – –
Citadel Advisors
9
Citadel Advisors
Florida
$48.3K +$68.8K +23,243 New
Renaissance Technologies
10
Renaissance Technologies
New York
$42K +$7.1K +2,400 +13%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$32K -$444 -150 -1%
Millennium Management
12
Millennium Management
New York
$31K +$44K +14,862 New
Northern Trust
13
Northern Trust
Illinois
$28K +$8.93K +3,017 +29%
CAN
14
Cetera Advisor Networks
California
$21K -$2.66K -900 -8%
SPIA
15
Steward Partners Investment Advisory
New York
$12.1K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$11K +$4.64K +1,567 +42%
UBS Group
17
UBS Group
Switzerland
$9.46K +$8.82K +2,980 +190%
Osaic Holdings
18
Osaic Holdings
Arizona
$6.07K – – –
AAS
19
Ameritas Advisory Services
Nebraska
$3.06K +$4.36K +1,473 New
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$1K +$1.69K +570 +57,000%
Wells Fargo
21
Wells Fargo
California
$390 – – –
BCM
22
Bourgeon Capital Management
Connecticut
$23 -$6 -2 -15%
Bank of America
23
Bank of America
North Carolina
$4 -$24 -8 -80%
PCFFS
24
Pacific Center for Financial Services
California
$3 +$3 +1 New
Barclays
25
Barclays
United Kingdom
$2 – – –
1
2

MBOT Hedge Fund Activity: Q1 2023 in Review

29 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q1 2023, worth a combined $2.94M — down 30% from $4.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new MBOT positions and 1 closed out — a net gain of 5 holders — while 7 added to existing stakes and 7 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $68.8K. The largest seller was Armistice Capital, cutting an estimated $266K.

  • 29 institutional investors held Microbot Medical (MBOT) as of Q1 2023, up from 24 in Q4 2022.
  • Funds reported $2.94M of Microbot Medical stock for Q1 2023, down 30% quarter-over-quarter.
  • 6 funds opened new Microbot Medical positions in Q1 2023 and 1 closed out, a net change of +5 holders.
  • The largest Microbot Medical buyer in Q1 2023 was Citadel Advisors, an estimated $68.8K added.
  • The largest Microbot Medical seller in Q1 2023 was Armistice Capital, an estimated $266K sold.

Based on aggregated 13F filings for Q1 2023.